About Ceretype Neuromedicine
Ceretype Neuromedicine is a private company based in Cambridge, Massachusetts. It has reported $1,775,000 raised in two offerings on Form D since November 2021. Its chief executive is Emily Stern.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 6, 2024 | Dec 18, 2025 | $400,000fully sold | 3 | $133K | Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 9, 2021 | Nov 22, 2021 | $1,375,000of $2.5M target | 8 | $171K | OptionsRule 506(b) | Form D ↗ |
| Total, two offerings | $1,775,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Ceretype Neuromedicine's Form D filed Dec 18, 2025.
DS
David Silbersweig
Director
ES
Emily Stern
Chief Executive Officer and director
RL
Richard Lipkin
Director
Earlier filings also listed Hong Pan (director, last listed Nov 2021).